Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Increased Awareness among Fresh Investors on Financial Health and Investment trends Business
  • Wholesale Inflation Turns Negative in India: June 2025 Sees Prices Slide Across Key Sectors National
  • Manish Malhotra Hosts India’s First Fashion Soirée Business
  • Inspirational Speaker Sonu Sharma’s “Believe In Yourself” in Ahmedabad for the first time Lifestyle
  • KUtility Provides Leading Bulk SMS And Social Media Marketing Services In India Business
  • Arihant Plus 2023 Review: A Smart Trading App for Investors & Traders Business
  • AlxTrip Launches Vendor Subscription Program: Ensures Revenue Growth And High-Quality Travel Leads Business
  • The Interim Budget for 2024 indicates a significant shift for India’s goal of achieving Net Zero status –  Mr. Deepak Rai, Managing Director Of Bootes- India’s First Net Zero Company Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • A 31-year-old who lived on a chair… until his spine finally said, ‘Enough’ Health
  • MagicTouch Brazil Approval: A Turning Point for Cardiovascular Innovation Health
  • Health Services Improved Immensely In Varanasi, Uttar Pradesh – Best Diagnostic Centre – Karauli Diagnostics Health
  • ACTIZEET Shilajit Emerges as the Pinnacle of Potency: 5x More Powerful than Other Shilajit Variants Health
  • On This World Spine Day Best Orthopedics Advice on Causes And Treatment Of Spine Pain Health
  • Dr Batra’s Launches XODerma – Non-Invasive Exosome-Based Skin Rejuvenation Treatment Health

Recent Posts

  • Vasu Healthcare Launches AI-Created ‘Naari Anthem’ Celebrating Strength and Care
  • Dr. Harvansh Chawla Appointed Chairman of BRISEC Chamber of Commerce & Industry; Steps Down from BRICS CCI to Assume Expanded Global Role
  • IPMAT Rohtak 2026 Concludes Successfully Across Examination Centres; LPT Releases Initial Exam Analysis
  • The Indian Doctor Leading a ‘Natural Birth’ Revolution: How Dr. Ranjitsinh Joja is Transforming Tribal Healthcare
  • At IIT Roorkee’s COMET’26, eduVelocity Guides Students on Strategic Global Education Planning

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Kingston Announces Pocket-Sized XS2000 Portable SSD and Record-Breaking DataTraveler Max USB 3.2 Gen 2 Flash Drive Business
  • IMPACT Stars Heath and Bhupinder guarantee Entertainment for all Entertainment
  • After Delivering 20K+ Orders, Noori-By-Nikita set to expand collections Business
  • Anaconda (2025): A Giant Snake With A Tiny Bite — Why Hollywood’s Bold Meta Reboot Slithers Between Charm And Misfire Entertainment
  • SPA Group—Frangipani Estates: Epitome of Quiet Luxury Business
  • India’s biggest IT challenge Business
  • Tax Consultants Chamber Announces Session on CCFS 2026 and Companies Act Changes Business
  • Renol Polychem’s Rs. 25.77 Crore IPO To Open On July 31 Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme